Table 2. Applications of human SMRT sequencing and clinical utility.
Target | Disease | Ref. |
---|---|---|
Tandem repeat sequencing | ||
FMR1 | Fragile X Syndrome | (43)a |
HTT | Huntington's Disease | a |
C9orf72 | Amyotrophic Lateral Sclerosis (ALS) | a |
SCA10 | Spinocerebellar ataxia type 10, Parkinson's disease | (10,53)a |
Highly polymorphic regions | ||
HLA | Autoimmune disorders & transplantation | (57–59) |
KIR | Autoimmune diseases & transplantation | (60) |
Pseudogene discrimination | ||
CYP2D6 | Drug metabolism | (61,63) |
PKD1 | Autosomal-dominant polycystic kidney disease | (64) |
IKBKG | Primary immunodeficiency diseases | (65) |
Cancer | ||
BCR-ABL1 | Chronic Myeloid Leukemia (CML) | (69) |
TP53 | Myelodysplastic Syndromes (MDS) and Acute Myeloblastic Leukemia (AML) | (70) |
Reproductive genomics | ||
TCOF1 | Treacher Collins syndrome | (67) |
PTPN11 | Noonan syndrome | (67) |
a bioRxiv https://doi.org/10.1101/203919.